Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-010647

CVP, Chief Financial Officer sold 11,250 shares at $71.68 ($806,406)

  • CVP, Chief Financial Officer acquired 11,250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ullem Scott B. · CVP, Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-09 Exercise or conversion : show line 1 in the form 10b5-1 +11,250 $45.28 $509,363 41,811 D
2024-12-09 Sale : show line 2 in the form 10b5-1 −11,250 $71.68 $806,406 30,561 D
Open-market sales · 11,250 sh · avg $71.68 · $806,406

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-09 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −11,250 45,000 D
Loading xslF345X05/doc4.xml…